# Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE

Study · id `cardio:ct-nct06853535` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06853535](<https://clinicaltrials.gov/study/NCT06853535>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06853535

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5138 participants.

## Technical summary

Registry record NCT06853535. Randomized; no masking; primary purpose prevention. Start 2025-05-23 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 5138 participants (planned count; ClinicalTrials.gov record NCT06853535, source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)
- Started: 2025-05-23 (actual) (ClinicalTrials.gov record NCT06853535, source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT06853535, source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06853535, source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06853535, source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06853535-2026-05-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE
- Acronym: PATH STROKE C
- Condition: Acute Ischemic Stroke
- Condition: Clopidogrel Resistance
- Intervention (Drug): The ticagrelor
- Intervention (Drug): The Clopidogrel
- Lead sponsor: Sichuan Provincial People's Hospital
- Lead sponsor class: OTHER
- Collaborator: Fudan University
- Collaborator class: OTHER
- Collaborator: Chengdu Medical College
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Sichuan Provincial People's Hospital (`cardio:org-sichuan-provincial-people-s-hospital`)
- Registry lists this organization as a collaborator: Fudan University (`cardio:org-fudan-university`)

## Provenance

Content hash: 74616b1265d7be4afa0ff7851297eeb52001bd97d2832c808fe60a33c3cba862
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
